GWSG
VTGN icon

GPS Wealth Strategies Group’s VistaGen Therapeutics VTGN Stock Holding History

GPS Wealth Strategies Group’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,441
Closed -$44.6K – 1405
2024
Q1 		$44.6K Hold
8,441
– – 0.01% 541
2023
Q4 		$43.4K Hold
8,441
– – 0.01% 519
2023
Q3 		$44.2K Hold
8,441
– – 0.01% 502
2023
Q2 		$15.8K Buy
8,441
+1
+0% +$4 ﹤0.01% 744
2023
Q1 		$31.6K Hold
8,440
– – 0.01% 595
2022
Q4 		$25.3K Buy
8,440
+8,202
+3,446% +$30.9K 0.01% 115
2022
Q3 		$1K Hold
238
– – ﹤0.01% 1112
2022
Q2 		$6K Buy
+238
New +$8.4K ﹤0.01% 865

Other funds holding VTGN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPS Wealth Strategies Group's VTGN Position: Q2 2024 in Review

GPS Wealth Strategies Group sold out of VistaGen Therapeutics (VTGN) in Q2 2024, closing a stake of 8,441 shares — an estimated $44.6K sold.

GPS Wealth Strategies Group first reported a position in VTGN in Q2 2022 and held it in 8 quarters. The position peaked at $44.6K in Q1 2024. 43 funds tracked by Wall St. Rank hold VTGN as of Q2 2024.

  • GPS Wealth Strategies Group reported no remaining VistaGen Therapeutics position as of Q2 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 8,441 VistaGen Therapeutics shares in Q2 2024, an estimated $44.6K.
  • GPS Wealth Strategies Group first reported a position in VistaGen Therapeutics in Q2 2022 and held it in 8 quarters.
  • GPS Wealth Strategies Group's VistaGen Therapeutics position peaked at $44.6K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q2 2024, filed 16 Jul 2024.